Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus

Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus

Anti-double stranded DNA (dsDNA) antibodies play an important role in the diagnosis, classification and management of systemic lupus erythematosus (SLE), an autoimmune disease characterized by heterogeneous clinical manifestations and a wide range of autoantibodies, which makes the diagnosis quite c...

Full description

Bibliographic Details
Main Authors:	Maria Infantino, Eszter Nagy, Nicola Bizzaro, Katarzyna Fischer, Xavier Bossuyt, Jan Damoiseaux
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Journal of Translational Autoimmunity
Subjects:	Anti-dsDNA antibodies Systemic lupus erythematosus Classification criteria Immunoassay Standardization
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589909021000599

Similar Items

Autoantibodies to dsDNA in the diagnosis, classification and follow-up of patients with systemic lupus erythematosus
by: Jan Damoiseaux, et al.
Published: (2023-01-01)

Comparisons of Anti-dsDNA Antibody Detection Methods by Chemiluminescent Immunoassay and Enzyme-Linked Immunosorbent Assay in Systemic Lupus Erythematosus
by: Huang-Chen Chang, et al.
Published: (2021-10-01)

CCR6+ Th cell distribution differentiates systemic lupus erythematosus patients based on anti-dsDNA antibody status
by: Wei Zhong, et al.
Published: (2018-02-01)

Fucosylation of anti-dsDNA IgG1 correlates with disease activity of treatment-naïve systemic lupus erythematosus patients
by: Jing Han, et al.
Published: (2022-03-01)

Estudo longitudinal do anticorpo antilipoproteína lipase e sua relação com atividade de doença nos indivíduos com lúpus eritematoso sistêmico sem anticorpos anti-dsDNA Longitudinal fluctuation of anti-lipoprotein lipase antibody is related with disease activity in systemic lupus erythematosus patients without anti-dsDNA antibodies
by: Jozélio Freire de Carvalho, et al.
Published: (2009-02-01)

The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be
by: Ole Petter Rekvig
Published: (2019-05-01)

Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus
by: Mi-Ae Lyu, et al.
Published: (2023-09-01)

The Effects of Flexibility on dsDNA–dsDNA Interactions
by: Chuanying Chen, et al.
Published: (2022-05-01)

Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas
by: Ole Petter Rekvig
Published: (2018-03-01)

Anti-DFS70 antibodies in systemic lupus erythematosus: Prevalence in a large Chinese cohort and an unexpected association with anti-dsDNA antibodies by a long-term follow-up
by: Yingxin Dai, et al.
Published: (2022-09-01)

Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus
by: Živković Valentina, et al.
Published: (2014-01-01)

The correlation between the levels of anti-dsDNA IgA antibody and the severity of systemic lupus erythematosus based on cutaneous vasculitis
by: H.P. Faridin, et al.
Published: (2022-07-01)

Comparative analysis of contemporary anti-double stranded DNA antibody assays for systemic lupus erythematosus
by: Claus-Juergen Bauer, et al.
Published: (2023-12-01)

Serum IgE anti-dsDNA autoantibodies in patients with proliferative lupus nephritis are associated with tubulointerstitial inflammation
by: Leran Chen, et al.
Published: (2023-12-01)

Increased binding of anti-dsDNA antibodies to short oligonucleotides modified with topoisomerase I reveals a potential new enzyme function independent from DNA relaxation
by: Manuela Frese-Schaper, et al.
Published: (2023-10-01)

Association of urine autoantibodies with disease activity in systemic lupus erythematosus
by: Yuxian Zhang, et al.
Published: (2024-01-01)

Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan
by: Patrick Muller, et al.
Published: (2020-07-01)

Risk factors for subsequent lupus nephritis in patients with juvenile-onset systemic lupus erythematosus: a retrospective cohort study
by: Tzu-Chuan Hsu, et al.
Published: (2023-03-01)

Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis
by: Daniele Faria Miguel, et al.
Published: (2020-02-01)

Clinical significance of antinucleosome antibodies in patients with “early” systemic lupus erythematosus
by: M. A. Kotovskaya, et al.
Published: (2016-05-01)

Anti-dsDNA B-Cell ELISpot as a Monitoring and Flare Prediction Tool in SLE Patients
by: Albert Pérez-Isidro, et al.
Published: (2023-02-01)

Structure and Dynamics of dsDNA in Cell-like Environments
by: Amar Singh, et al.
Published: (2022-11-01)

Utilidade da triagem dos anticorpos anti-dsDNA por quimioluminescência, seguida de confirmação por imunofluorescência indireta
by: Maria Roseli Monteiro Callado, et al.
Published: (2013-10-01)

Released dsDNA‐triggered inflammasomes serve as intestinal radioprotective targets
by: Long Chen, et al.
Published: (2023-01-01)

Endoparasitoid lifestyle promotes endogenization and domestication of dsDNA viruses
by: Benjamin Guinet, et al.
Published: (2023-06-01)

Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-up
by: Yen-Nung Liao, et al.
Published: (2011-07-01)

Tracing dsDNA Virus–Host Coevolution through Correlation of Their G-Quadruplex-Forming Sequences
by: Natália Bohálová, et al.
Published: (2021-03-01)

Pulmonary Manifestations of Systemic Lupus Erythematosus Among Adults in Aseer Region, Saudi Arabia
by: Alhammadi NA, et al.
Published: (2024-03-01)

Anti‐dsDNA, anti‐nucleosome, anti‐C1q, and anti‐histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity
by: Xiaoying Shang, et al.
Published: (2021-06-01)

In situ Electrochemical Evaluation of the Interaction of dsDNA with the Proteasome Inhibitor Anticancer Drug Bortezomib
by: Mihaela-Cristina Bunea, et al.
Published: (2023-04-01)

Identificación de predictores serológicos de recaída en pacientes con lupus eritematoso sistémico: estudio prospectivo de 12 meses
by: Elena Kokuina, et al.

Electrochemical characteristics of prednisone and its interaction with dsDNA over functionalized CNSs modified electrode
by: Srikant Sahoo, et al.
Published: (2022-05-01)

Anti-dsDNA negative and anti-Ro positive lupus nephritis: a report of a rare case
by: D. Jain, et al.
Published: (2014-03-01)

Evaluation of Anti-Nuclear Antibodies and Anti-dsDNA Serum Levels in Patients with Suspected Systemic Lupus Erythematosus
by: Mana Zakeri, et al.
Published: (2023-03-01)

Um caso de Nefrite de shunt associada a elevação transitória de anticorpos anti-dsDNA
by: Marta Soares, et al.
Published: (2014-09-01)

Cytokine Storm as a Cellular Response to dsDNA Breaks: A New Proposal
by: Snehal Shabrish, et al.
Published: (2021-02-01)

The greatest contribution to medical science is the transformation from studying symptoms to studying their causes—the unrelenting legacy of Robert Koch and Louis Pasteur—and a causality perspective to approach a definition of SLE
by: Ole Petter Rekvig, et al.
Published: (2024-02-01)

Correlation of Autoantibodies Presence Detected By IFA-anti-dsDNA, IFA-AMA and Immunoblotting with Corresponding Data in Clinical Management of Autoimmune Diseases
by: Đemo Subašić, et al.
Published: (2008-02-01)

The ecogenomics of dsDNA bacteriophages in feces of stabled and feral horses
by: V.V. Babenko, et al.
Published: (2020-01-01)

Anti-Sm antibodies in the classification criteria of systemic lupus erythematosus
by: Joyce J.B.C. van Beers, et al.
Published: (2022-01-01)